Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?
Ahmad Hassan, Janet Lin, Nicole Ricker, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 199-199
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

PhageLeads: Rapid Assessment of Phage Therapeutic Suitability Using an Ensemble Machine Learning Approach
Yukgehnaish Kumarasan, Heera Rajandas, Sivachandran Parimannan, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 342-342
Open Access | Times Cited: 73
Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine model
Julia D. Berkson, Claire E. Wate, Garrison B. Allen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Bacteriophage and endolysin engineering for biocontrol of food pathogens/pathogens in the food: recent advances and future trends
Chanyoung Lee, Hyeongsoon Kim, Sangryeol Ryu
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 27, pp. 8919-8938
Open Access | Times Cited: 47
Phage therapy: A renewed approach against oral diseases caused by Enterococcus faecalis infections
Dan Yang, Yingying Xiang, Fei Song, et al.
Microbial Pathogenesis (2024) Vol. 189, pp. 106574-106574
Closed Access | Times Cited: 8
Nearly complete structure of bacteriophage DT57C reveals architecture of head-to-tail interface and lateral tail fibers
Rafael Ayala, Andrey Moiseenko, Ting-Hua Chen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Synergistic Antimicrobial Effects of Phage vB_AbaSi_W9 and Antibiotics against Acinetobacter baumannii Infection
Yoon-Jung Choi, Shukho Kim, Minsang Shin, et al.
Antibiotics (2024) Vol. 13, Iss. 7, pp. 680-680
Open Access | Times Cited: 7
A systematic review from basics to omics on bacteriophage applications in poultry production and processing
Md. Rashedul Islam, Carlos E. Martinez-Soto, Janet Lin, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 18, pp. 3097-3129
Closed Access | Times Cited: 34
Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics
Sani Sharif Usman, Abdullahi İbrahim Uba, Evangeline Christina
Molecular Biology Reports (2023) Vol. 50, Iss. 8, pp. 7055-7067
Closed Access | Times Cited: 14
Bacteriophage-mediated approaches for biofilm control
Arianna Mayorga-Ramos, Saskya E. Carrera-Pacheco, Carlos Barba‐Ostria, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Closed Access | Times Cited: 5
The gut microbiota in retinal diseases
Marie-Agnès Bringer, Pierre‐Henry Gabrielle, Alain M. Bron, et al.
Experimental Eye Research (2021) Vol. 214, pp. 108867-108867
Open Access | Times Cited: 32
Growth-Dependent Predation and Generalized Transduction of Antimicrobial Resistance by Bacteriophage
Quentin J. Leclerc, Jacob Wildfire, Arya Gupta, et al.
mSystems (2022) Vol. 7, Iss. 2
Open Access | Times Cited: 19
More’s the Same—Multiple Hosts Do Not Select for Broader Host Range Phages
Jupiter Myers, Joshua S. Davis, Megan Lollo, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 518-518
Open Access | Times Cited: 12
DP1, a multifaceted synthetic peptide: Mechanism of action, activity and clinical potential
Mayank Maan, Hemant Goyal, Shubhi Joshi, et al.
Life Sciences (2024) Vol. 340, pp. 122458-122458
Closed Access | Times Cited: 4
Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii
Md Minarul Islam, Nasir Uddin Mahbub, Woo Shik Shin, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
Anti-Infective Bacteriophage Immobilized Nitric Oxide-Releasing Surface for Prevention of Thrombosis and Device-Associated Infections
Vijay Singh Gondil, Morgan Ashcraft, Sama Ghalei, et al.
ACS Applied Bio Materials (2025)
Open Access
Enhancing phage therapy by coating single bacteriophage-infected bacteria with polymer to preserve phage vitality
Sisi Lin, Guocheng Xie, Jun He, et al.
Nature Biomedical Engineering (2025)
Closed Access
Characterization of Novel Straboviridae Phages Enhancing Antibiotic Efficacy and Biofilm Inhibition Against MDR Escherichia coli
Md Shamsuzzaman, Shukho Kim, Yoon-Jung Choi, et al.
Research Square (Research Square) (2025)
Closed Access
Global perspectives on residual antibiotics: environmental challenges and trends
Rohit Thakur, Adarsh Singh, Rashmi Dhanwar, et al.
Discover Sustainability (2025) Vol. 6, Iss. 1
Open Access
Reviving hope: Phage therapy application for antimicrobial resistance in farm animal production over the past decade
Mebratu Melaku, Junhong Wang, Yining Xie, et al.
Animal Feed Science and Technology (2025), pp. 116333-116333
Open Access
Characterization of a new lytic bacteriophage (vB_KpnM_KP1) targeting Klebsiella pneumoniae strains associated with nosocomial infections
José Molina-López, Berenice Simon-Olea, María del Rosario Espinoza-Mellado, et al.
Virology (2025), pp. 110526-110526
Open Access
Modelling the synergistic effect of bacteriophage and antibiotics on bacteria: Killers and drivers of resistance evolution
Quentin J. Leclerc, Jodi A. Lindsay, Gwenan M. Knight
PLoS Computational Biology (2022) Vol. 18, Iss. 11, pp. e1010746-e1010746
Open Access | Times Cited: 17
How Good are Bacteriophages as an Alternative Therapy to Mitigate Biofilms of Nosocomial Infections
Aditi Singh, Sudhakar Padmesh, Manish Dwivedi, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 503-532
Open Access | Times Cited: 16
Benefits and Challenges of Applying Bacteriophage Biocontrol in the Consumer Water Cycle
Brandon Reyneke, Benjamin Havenga, Monique Waso, et al.
Microorganisms (2024) Vol. 12, Iss. 6, pp. 1163-1163
Open Access | Times Cited: 3
Bacteriophage and their lysins: A new era of biocontrol for inactivation of pathogenic bacteria in poultry processing and production—A review
Sangha Han, Kye-Hwan Byun, Md. Furkanur Rahaman Mizan, et al.
Food Control (2022) Vol. 137, pp. 108976-108976
Closed Access | Times Cited: 13
Therapeutic Phage Candidates for Targeting Prevalent Sequence Types of Carbapenem-Resistant Escherichia coli
Md Shamsuzzaman, Shukho Kim, Yoon-Jung Choi, et al.
Foodborne Pathogens and Disease (2024) Vol. 21, Iss. 11, pp. 681-688
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top